Skip to main content
    N

    Nuvectis Pharma Inc (NVCT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $19.11
    -1.13 (-5.58%)

    Market Cap: $696.03M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Nuvectis Pharma Inc (NVCT) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Nuvectis Pharma are Nuvation Bio (NUVB), Nektar Therapeutics (NKTR) and Janux Therapeutics (JANX). By market cap, Nuvectis Pharma ranks 7th of the 13 companies on this page; Nuvation Bio (NUVB) is the largest at $1.41B. The median P/E of the 3 companies with a P/E is 39.3x.

    Peer Comparison

    NVCT's revenue growth of 0.0% is above the peer median of -1.5%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Nuvectis Pharma (NVCT)$696.03MN/AN/A0.0%N/A0.0%0.00%
    Nuvation Bio Inc (NUVB)$1.41BN/A6.7x-67.4%-18.7%242.6%0.00%
    Nektar Therapeutics (NKTR)$1.27BN/A23.9x0.0%N/A-20.4%0.00%
    Janux Therapeutics Inc (JANX)$695.65MN/A29.6x0.0%N/A-7.1%0.00%
    Pharming Group NV (PHAR)$891.80M39.3x2.4x6.3%7.9%20.8%0.00%
    Corvus Pharmaceuticals Inc (CRVS)$897.52MN/AN/A0.0%N/A0.0%0.00%
    Theravance Biopharma Inc (TBPH)$884.18M95.1x8.4x51.6%N/A-20.9%0.00%
    DBV Technologies (DBVT)$692.19MN/AN/A0.0%-130.3%-42.9%0.00%
    Cullinan Oncology LLC (CGEM)$667.39MN/AN/A0.0%N/A0.0%0.00%
    Zevra Therapeutics Inc. (ZVRA)$540.30M11.6x3.7x52.8%N/A44.9%0.00%
    Adlai Nortye Ltd. American Depositary Shares (ANL)$683.26MN/A8.1x-124.8%-7.3%178.1%0.00%
    Valneva SE ADR (VALN)$538.42MN/A3.2x-110.3%-44.2%-27.7%0.00%
    Novavax Inc (NVAX)$1.41BN/A3.2x-18.6%-66.6%-3.0%0.00%
    Peer median$789.92M39.3x6.7x0.0%-31.4%-1.5%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Nuvectis Pharma, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Nuvation Bio Inc (NUVB)
    Nuvation Bio Inc., a clinical-stage biopharmaceutical company, is focused on developing therapeutic candidates for oncology.
    NUVB competitors
    Nektar Therapeutics (NKTR)
    Nektar Therapeutics is a biopharmaceutical company.
    NKTR competitors
    Janux Therapeutics Inc (JANX)
    Janux Therapeutics, Inc., a biopharmaceutical company, develops therapies based on the patented Tumor Activated T Cell Engager (TRACTr) platform technology...
    JANX competitors
    Pharming Group NV (PHAR)
    Pharming Group NV, a specialty pharmaceutical company, develops products for the treatment of rare diseases and unmet medical needs in the United States...
    PHAR competitors
    Corvus Pharmaceuticals Inc (CRVS)
    Corvus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies.
    CRVS competitors
    Theravance Biopharma Inc (TBPH)
    Theravance Biopharma, Inc., a diversified biopharmaceutical company, discovers, develops, and markets organ-selective drugs in the United States, Europe...
    DBV Technologies (DBVT)
    DBV Technologies SA, a clinical-stage biopharmaceutical company, is dedicated to the research and development of epicutaneous immunotherapy products.
    DBVT competitors
    Cullinan Oncology LLC (CGEM)
    Cullinan Management, Inc., a biopharmaceutical company, is focused on developing a line of targeted oncology and immuno-oncology therapies for cancer patients...
    CGEM competitors
    Zevra Therapeutics Inc. (ZVRA)
    Zevra Therapeutics, Inc., a rare disease company melding science, discovers and develops various proprietary prodrugs to treat serious medical conditions...
    ZVRA competitors
    Adlai Nortye Ltd. American Depositary Shares (ANL)
    Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China.
    Valneva SE ADR (VALN)
    Valneva SE, a company specialized in vaccines, focused on the development and commercialization of prophylactic vaccines for infectious diseases with unmet...
    VALN competitors
    Novavax Inc (NVAX)
    Novavax, Inc., a biotechnology company, focuses on the discovery, development and commercialization of vaccines to prevent serious infectious diseases...
    NVAX competitors

    Frequently Asked Questions About NVCT

    Who are Nuvectis Pharma's main competitors?

    The companies most similar to Nuvectis Pharma include Nuvation Bio (NUVB), Nektar Therapeutics (NKTR), Janux Therapeutics (JANX), Pharming Group NV (PHAR) and Corvus Pharmaceuticals (CRVS), listed from the closest match.

    Who is Nuvectis Pharma's biggest competitor?

    Nuvation Bio (NUVB) is both the largest of the similar companies at $1.41B and the closest match by business profile, size, sector and industry.

    How does NVCT stock compare with its competitors?

    NVCT's net margin is 0.0% against a peer median of 0.0%.

    Which of Nuvectis Pharma's competitors pays a higher dividend?

    Nuvectis Pharma pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Nuvectis Pharma bigger than its competitors?

    No. Nuvectis Pharma is 7th by market cap among the 13 companies on this page; the largest is Nuvation Bio (NUVB) at $1.41B.